Stay updated on Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.

Latest updates to the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a new revision of the page content. This reflects a minor behind-the-scenes update rather than visible content changes.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision: v3.6.2 appears on the page, replacing the prior v3.6.0. This reflects a site update/version bump rather than a change to the study information.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page now includes new user-guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows the study status as completed with No longer looking for participants. A formatting tweak standardizes the Intervention/Treatment label and the revision note updates to Revision: v3.6.0.SummaryDifference0.5%

- Check37 days agoChange DetectedRevision: v3.5.5 replaces the prior v3.5.4 in the page metadata, indicating a small update to the page without altering study information.SummaryDifference0.1%

- Check59 days agoChange DetectedThe study's revision label updated to v3.5.4 in the documents section, replacing the previous v3.5.3, signaling a minor update to the protocol materials.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a new version of the page. This update seems administrative and does not affect the study details shown.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.